相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups
Michael Weller et al.
ACTA NEUROPATHOLOGICA (2015)
Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis
Sabine Spiegl-Kreinecker et al.
NEURO-ONCOLOGY (2015)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
Mohamed Ali Mosrati et al.
ONCOTARGET (2015)
TERT promoter mutations and telomere length in adult malignant gliomas and recurrences
Barbara Heidenreich et al.
ONCOTARGET (2015)
TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas
Matthias Simon et al.
NEURO-ONCOLOGY (2015)
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations
M. Labussiere et al.
BRITISH JOURNAL OF CANCER (2014)
TERT promoter mutations in cancer development
Barbara Heidenreich et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas
Kathleen Dorris et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Michael Weller et al.
LANCET ONCOLOGY (2014)
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk
Kyle M. Walsh et al.
NATURE GENETICS (2014)
Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types
Nils J. Fredriksson et al.
NATURE GENETICS (2014)
Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes
Marianne Labussiere et al.
NEUROLOGY (2014)
TERT Promoter Mutations Lead to High Transcriptional Activity under Hypoxia and Temozolomide Treatment and Predict Poor Prognosis in Gliomas
Chen Chen et al.
PLOS ONE (2014)
被撤回的出版物: Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis (Retracted article. See vol. 36, pg. 7309, 2015)
Wei-Zhong Xiao et al.
TUMOR BIOLOGY (2014)
Telomerase promoter mutations in cancer: an emerging molecular biomarker?
Joao Vinagre et al.
VIRCHOWS ARCHIV (2014)
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas
Patrick J. Killela et al.
ONCOTARGET (2014)
IDH Mutation in Glioma: New Insights and Promises for the Future
Zorbey Turkalp et al.
JAMA NEUROLOGY (2014)
TERT promoter mutations in primary and secondary glioblastomas
Naosuke Nonoguchi et al.
ACTA NEUROPATHOLOGICA (2013)
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Marc Remke et al.
ACTA NEUROPATHOLOGICA (2013)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis
Hairui Sun et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age
Daniela Loetsch et al.
NEURO-ONCOLOGY (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis
Hong-Bin Cheng et al.
TUMOR BIOLOGY (2013)
Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?
Nanne K. Kloosterhof et al.
LANCET ONCOLOGY (2011)
Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers
Michael Jansen et al.
LANCET NEUROLOGY (2010)
Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity
Jaime L. Peters et al.
STATISTICS IN MEDICINE (2007)
MYC amplification and TERT expression in breast tumor progression
Sigridur K. Bodvarsdottir et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Telomerase reverse transcriptase (TERT) expression and proliferation in canine brain tumours
S. Long et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2006)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
分享论文
